MYONAL 50MG TABLETS 30S

MYONAL 50MG TABLETS 30S
Myonal 50 MG Sugar-Coated Tablet, 30's
Indication
Improvement of myotonic conditions caused by the following diseases: Neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain.
Spastic paralysis caused by the following diseases: Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, sequelae of surgical trauma (including cerebrospinal tumor), sequelae of trauma (spinal injury and head injury), amyotrophic lateral sclerosis, infantile cerebral palsy, spinocerebellar degeneration, spinal vascular disorder, subacute myelo-optico neuropathy (SMON) and other encephalomyelopathies.
Dosage and administration
Usually for adults, administer orally 3 tablets (150 MG of eperisone hydrochloride) a day in three divided doses after meals. The dosage should be adjusted according to the patient age and severity of symptoms.
Adverse Reaction
Shock and anaphylactoid reactions: Since shock and anaphylactoid reactions may occur, patients should be carefully observed. In the event of symptoms such as redness, itching, urticaria, edema of the face or other parts and dyspnea etc., treatment should be discontinued and appropriate measures should be taken.
Oculo-muco-cutaneous syndrome (Stevens-Johnson syndrome) and toxic epidermal necrolysis (Lyell syndrome): Serious dermatopathy such as oculo-muco-cutaneous syndrome (Stevens-Johnson syndrome) or toxic epidermal necrolysis (Lyell syndrome) may occur. Patients should be carefully observed, treatment discontinued and appropriate measures taken, in the event of symptoms such as fever, erythema, blistering, itching, ocular congestion or stomatitis, etc.